From: On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
Subtype | Covariate | Hazard ratio (95% CI) | P |
---|---|---|---|
HR−/HER2− | tu− vs. tu+ | 0.402 (0.163–0.987) | 0.047 |
HR+/HER2− | tu− vs. tu+ | 1.039 (0.428–2.525) | 0.933 |
HER2+ | tu− vs. tu+ | 1.77 (0.577–5.43) | 0.318 |